Managed Healthcare Executive June 16, 2022
Legislation that would establish benefit categories for digital therapeutics has been introduced in Congress.
Although the idea of smartphones as personal health devices has become common among the general public, the integration of that idea into the formal regulatory and payment structure remains very much a work in progress.
One potential milestone could be on the horizon. Congress is considering legislation called the Access to Prescription Digital Therapeutics Act of 2022, a bipartisan bill that would establish benefit categories for certain digital therapeutics so that they could be reimbursed by Medicare, Medicaid and other public payers. Versions of the bill were introduced in both the House and Senate in March.Proponents, including the Digital Therapeutics Alliance, an industry trade group, argue...
Today's Sponsors
Today's Sponsor